1. Technologies
10-2015-950

Mirna for the Treatment of Metastatic Breast Cancer

Metastasis is the primary cause for mortality in breast cancer.
We showed that breast cancer metastasis can be prevented by miR-96 or miR-182 treatment. We found that miR-96/miR-182 downregulates Palladin protein levels, thereby reducing breast cancer cell migration and invasion.
A hydrogel-embedded, gold-nanoparticle-based delivery vehicle provides efficient local, selective, and sustained release of miR-96/miR-182, markedly suppressing metastasis in a breast cancer mouse model. Combined delivery of the miRNAs with a chemotherapy drug, cisplatin, enables significant primary tumor shrinkage and metastasis prevention.

Stage of Development
In Vivo proof of concept. Additional delivery systems are investigated.
Intellectual Property
Granted US and Europe patents.
References
“Local microRNA delivery targets Palladin and prevents metastatic breast cancer”. Nature communications 7 (1), 1-14, 2016

Associated Business Development manager

Tali Aloya, PhD
VP, Business Development, Life Sciences
+972.3.6405063

Researchers

Prof.
Shomron Noam
6 Technologies
View Shomron Noam Profile

More related technologies

BiomarkersEarly and Accurate Categorization and Identification of the Pathogen Infection BioinformaticsAn early stage screening tool for distinguishing pregnant women having an increased risk of developing preeclampsia A Cytoskeletal Protein Predicts Disease Incidence, Progression, and Prognosis BiomarkersNew MicroRNAs as Candidates for Depression Therapy Bone / CartilageAutomatic Detection of Spinal Pathologies Based on MRI Scans
+972-3-6406608      
Sign up for
our events

    Close
    Life Science
    Magazine

      Close
      Hi-Tech
      Magazine

        Close